Towerpoint Wealth LLC bought a new stake in Israel Chemicals Ltd (NYSE:ICL) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 19,255 shares of the basic materials company’s stock, valued at approximately $96,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Lindbrook Capital LLC increased its holdings in shares of Israel Chemicals by 149.6% in the 3rd quarter. Lindbrook Capital LLC now owns 5,472 shares of the basic materials company’s stock valued at $27,000 after purchasing an additional 3,280 shares during the period. Parallel Advisors LLC increased its holdings in shares of Israel Chemicals by 126.1% in the 3rd quarter. Parallel Advisors LLC now owns 7,364 shares of the basic materials company’s stock valued at $37,000 after purchasing an additional 4,107 shares during the period. Eaton Vance Management acquired a new position in shares of Israel Chemicals in the 2nd quarter valued at about $58,000. Signaturefd LLC increased its holdings in shares of Israel Chemicals by 30.1% in the 2nd quarter. Signaturefd LLC now owns 13,119 shares of the basic materials company’s stock valued at $68,000 after purchasing an additional 3,038 shares during the period. Finally, First Trust Advisors LP acquired a new position in shares of Israel Chemicals in the 1st quarter valued at about $73,000. Institutional investors own 6.63% of the company’s stock.
Separately, Zacks Investment Research raised Israel Chemicals from a “sell” rating to a “hold” rating in a research note on Tuesday, October 29th.
Shares of NYSE ICL traded up $0.04 during trading hours on Friday, hitting $4.60. The stock had a trading volume of 109,167 shares, compared to its average volume of 158,197. The company has a market capitalization of $5.94 billion, a P/E ratio of 12.43, a P/E/G ratio of 1.19 and a beta of 0.89. The firm’s 50-day moving average price is $4.68 and its two-hundred day moving average price is $5.02. Israel Chemicals Ltd has a 52 week low of $4.36 and a 52 week high of $6.48. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.85 and a current ratio of 1.51.
Israel Chemicals (NYSE:ICL) last announced its quarterly earnings results on Thursday, November 7th. The basic materials company reported $0.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.01. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Israel Chemicals had a return on equity of 14.03% and a net margin of 9.04%. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.10 EPS. As a group, analysts expect that Israel Chemicals Ltd will post 0.41 EPS for the current fiscal year.
Israel Chemicals Company Profile
Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
Featured Article: What is a Candlestick Chart?
Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.